C12N 2760/18561
Methods of inactivation or attenuation
C12N2760/18561 (Methods of inactivation or attenuation) appears on 70 US grants and 98 published applications in this corpus.
Search patents in C12N- Granted patents
- 70
- Published applications
- 98
- Assignees
- 64
- Inventors
- 137
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 3 |
| 2004 | 4 | 5 |
| 2005 | 2 | 10 |
| 2006 | 0 | 8 |
| 2007 | 1 | 3 |
| 2008 | 3 | 3 |
| 2009 | 3 | 5 |
| 2010 | 9 | 4 |
| 2011 | 0 | 2 |
| 2012 | 0 | 3 |
| 2013 | 0 | 2 |
| 2014 | 2 | 3 |
| 2015 | 2 | 8 |
| 2016 | 1 | 2 |
| 2017 | 5 | 3 |
| 2018 | 3 | 6 |
| 2019 | 3 | 6 |
| 2020 | 5 | 4 |
| 2021 | 4 | 3 |
| 2022 | 7 | 4 |
| 2023 | 0 | 5 |
| 2024 | 3 | 2 |
| 2025 | 4 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for inactivating and storing respiratory syncytial virus14 Apr 2026US 12,600,750 B2Xiamen Innovax Biotech Co., Ltd.
- Modified RSV F proteins and methods of their use15 Jul 2025US 12,357,684 B2
- Chimeric RSV, immunogenic compositions, and methods of use25 Mar 2025US 12,257,296 B2Emory University
- Methods and compositions for treating negative-sense single-stranded RNA virus18 Feb 2025US 12,227,769 B2Nationwide Children's Hospital, Inc.
- Recombinant RSV with silent mutations, vaccines, and methods related thereto7 Jan 2025US 12,186,386 B2Emory University and Children's Healthcare of Atlanta, Inc.
- RSV Vaccines with Truncated G-Protein Mucin Domains30 Apr 2026US 2026/0115274 A1Butler University
- Methods and compositions for treating negative-sense single-stranded rna virus7 Aug 2025US 2025/0250548 A1Nationwide Children's Hospital, Inc.
- Multivalent vaccine for paramyxoviruses and uses thereof22 May 2025US 2025/0161436 A1Icosavax, Inc.
- Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization19 Dec 2024US 2024/0417699 A1The Research Foundation for The State University of New York
- Method of eliciting an immune response against respiratory syncytial virus23 May 2024US 2024/0165217 A1Codagenix Inc.
Most cited
By later US patents
- Attenuated respiratory syncytial virus vaccine compositions56US 5,922,326 AThe United States of America as represented by the Department of Health and Human Services · 1999
- Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences39US 5,993,824 AThe United States of America as represented by the Department of Health and Human Services · 1999
- Production of viral antigens37US 4,517,304 ANational Research Development Corporation · 1985
- Production of cell strains capable of propagating respiratory syncytial virus, compositions containing such virus and their use in diagnosis of respiratory syncytial virus infection31US 5,071,758 ANational Research Development Corporation · 1991
- Attenuated chimeric respiratory syncytial virus31US 7,846,455 B2The United States of America as represented by the Department of Health and Human Services · 2010